53 results on '"Higashi, Yasuyuki"'
Search Results
2. Crosslinked Structure of Polyacrylic Acid Affects Pulmonary Fibrogenicity in Rats
3. Effect of Different Molecular Weights of Polyacrylic Acid on Rat Lung Following Intratracheal Instillation
4. Pulmonary disorder induced by cross‐linked polyacrylic acid
5. Waterproof spray‐induced lung injury while using a heater
6. Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib
7. Evaluation of the Influence of the Experience and Training of EBUS-TBNA on Diagnostic Rate and Safety
8. A Case of Left Upper Lobe Lung Cancer Successfully Diagnosed by Transesophageal Endoscopic Ultrasound with Bronchoscope-Guided Fine Needle Aspiration Alone
9. Benefits of a loading dose of tacrolimus on graft survival of kidney transplants in nonhuman primates
10. Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model
11. Discovery of tricyclic dipyrrolopyridine derivatives as novel JAK inhibitors
12. Corrigendum to “Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3” [Bioorg. Med. Chem. 23 (2015) 4871–4883]
13. A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model
14. The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates
15. Immunosuppressive effect of ASP2408, a novel CD86-selective variant of CTLA4-Ig, in rats and cynomolgus monkeys
16. Corrigendum to “Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3” [Bioorg. Med. Chem. 23 (2015) 4871–4883]
17. A chronic renal rejection model with a fully MHC-mismatched rat strain combination under immunosuppressive therapy
18. Inhibition of c-Rel DNA binding is critical for the anti-inflammatory effects of novel PIKfyve inhibitor
19. ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution
20. Effect of novel PKCθ selective inhibitor AS2521780 on acute rejection in rat and non-human primate models of transplantation
21. Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3
22. Discovery of 3,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2(1H)-one derivatives as novel JAK inhibitors
23. Release mechanisms of tacrolimus-loaded PLGA and PLA microspheres and immunosuppressive effects of the microspheres in a rat heart transplantation model
24. Synthesis and Evaluation of 1H-Pyrrolo[2,3-b]pyridine Derivatives as Novel Immunomodulators Targeting Janus Kinase 3
25. Effect of AS2521780, a novel PKCθ selective inhibitor, on T cell-mediated immunity
26. JAK inhibitors as a new generation of small-molecule immunosuppressants
27. Anti-inflammatory effect and selectivity profile of AS1940477, a novel and potent p38 mitogen-activated protein kinase inhibitor
28. Effect of recombinant human transforming growth factor β1 on immune responses in patients with chronic hepatitis B
29. A Comparison of Protocols Used to Generate Insulin-Producing Cell Clusters from Mouse Embryonic Stem Cells
30. Efficacy of Oral Treatment With Tacrolimus in the Renal Transplant Model in Cynomolgus Monkeys
31. FK1706, a novel non-immunosuppressive immunophilin: neurotrophic activity and mechanism of action
32. Topical Application of FK506 (Tacrolimus) Ointment Inhibits Mite Antigen-Induced Dermatitis by Local Action in NC/Nga Mice
33. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids)
34. Atopic Dermatitis-Like Skin Lesions Induced by Topical Application of Mite Antigens in NC/Nga Mice
35. FK506 suppresses neutrophil chemoattractant production by peripheral blood mononuclear cells
36. Role of Inhibition of Penicillin Binding Proteins and Cell Wall Cross-Linking by Beta-Lactam Antibiotics in Low- and High-Level Methicillin Resistance of Staphylococcus aureus
37. Biochemical and pharmacological characterization of FK706, a novel elastase inhibitor
38. Deficiency of antibody response to hypervariable region of hepatitis C virus in patients with chronic hepatitis C
39. Predictive factors in the response to interferon therapy in chronic hepatitis C
40. Hepatitis C virus genotypes are not responsible for development of serious liver disease
41. Dynamics of Genome Change in the E2/NS1 Region of Hepatitis C Virus in Vivo
42. Comparison of Envelope and Precore/Core Variants of Hepatitis B Virus (HBV) during Chronic HBV Infection
43. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C
44. A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C
45. Pilot study of ribavirin and interferon-β for chronic hepatitis B
46. Animal pharmacokinetics of FK037, a novel parenteral broad-spectrum cephalosporin.
47. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
48. Effects of transforming growth factor‐β1 against the inhibitory action of interferon on DNA synthesis and viral replication in hepatitis B virus DNA‐transfected cell
49. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: Relationship to genotypes of hepatitis C virus
50. Activation of aspartase by site-directed mutagenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.